Lonza walkersville, INC.:1110291 [21-033945]
Ended Awarded
- Contract number
- 75N91021F00001
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,000
Award facts
- Contract value 100% obligated
- $18,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc. received a $18K Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI), a component of the National Institutes of Health under the Department of Health and Human Services. This firm fixed-price contract, awarded on May 24, 2021, with an ultimate completion date of December 24, 2021, was issued without a set-aside designation, indicating open competition. The work will be performed at Lonza Walkersville's facility in Walkersville, Maryland. As a foreign-owned manufacturer specializing in biological materials and laboratory equipment, Lonza Walkersville supplies high-precision research products essential to the federal biomedical research enterprise.
This award represents a call against Lonza Walkersville's existing $10M single-award BPA with the HHS Office of Logistics and Acquisition Operations, valid through December 31, 2025. The company's contract portfolio with federal agencies demonstrates consistent provision of specialized research equipment and biological materials, including cell culture media, cell lines, transfection devices, and automated cell processing systems. Such materials and equipment directly support NCI's cancer research initiatives and the broader research missions across multiple NIH institutes, enabling critical work in oncology, infectious disease, regenerative medicine, and cellular engineering.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Lonza Walkersville, Inc. by National Cancer Institute (National Institutes of Health) on May 24, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $18,000 on 75N91021F00001.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a BPA call under HHSN263201600052B, a blanket purchase agreement.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award